Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
Meletios Α. Dimopoulos(National and Kapodistrian University of Athens), Philippe Moreau, Evangelos Terpos(National and Kapodistrian University of Athens), María‐Victoria Mateos(Instituto de Investigación Biomédica de Salamanca), Sonja Zweegman(Amsterdam University Medical Centers), Gordon Cook(University of Leeds), Michel Delforge(KU Leuven), Roman Hájek(University Hospital Ostrava), Fredrik Schjesvold(Oslo University Hospital), Michèle Cavo, Hartmut Goldschmidt(Heidelberg University), Thierry Façon(Hôpital Claude Huriez), Hermann Einsele(Universitätsklinikum Würzburg), Mario Boccadoro(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Jesús F. San Miguel(Clinica Universidad de Navarra), Pieter Sonneveld(Erasmus MC Cancer Institute), Ulrich Mey(Kantonsspital Graubünden)
Cited by 815Open Access
Abstract
Related Papers
Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
Jesús F. San Miguel, Rudolf Schlag, Nuriet K. Khuageva et al.|New England Journal of Medicine|2008|1.9k
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
A. Keith Stewart, S. Vincent Rajkumar, Meletios Α. Dimopoulos et al.|New England Journal of Medicine|2014|1.3k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister et al.|New England Journal of Medicine|2012|1.1k